Frontiers in Cellular and Infection Microbiology (Aug 2023)
Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
- Kaikai Yu,
- Bin Liu,
- Haotian Yu,
- Chengbiao Sun,
- Xuefeng Wang,
- Guorui Li,
- Mingxin Dong,
- Yan Wang,
- Jianxu Zhang,
- Na Xu,
- Wensen Liu
Affiliations
- Kaikai Yu
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Bin Liu
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
- Haotian Yu
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Chengbiao Sun
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Xuefeng Wang
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Guorui Li
- College of Life Sciences and Food Engineering, Inner Mongolia Minzu University, Tongliao, China
- Mingxin Dong
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Yan Wang
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Jianxu Zhang
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- Na Xu
- Academic Affairs Office, Jilin Medical University, Jilin, Jilin, China
- Wensen Liu
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China
- DOI
- https://doi.org/10.3389/fcimb.2023.1264974
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
